145 related articles for article (PubMed ID: 38165808)
21. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.
Caviglia GP; Abate ML; Tandoi F; Ciancio A; Amoroso A; Salizzoni M; Saracco GM; Rizzetto M; Romagnoli R; Smedile A
J Hepatol; 2018 Aug; 69(2):301-307. PubMed ID: 29621551
[TBL] [Abstract][Full Text] [Related]
22. Clinical implication of immune checkpoint inhibitor on the chronic hepatitis B virus infection.
Hagiwara S; Nishida N; Ida H; Ueshima K; Minami Y; Takita M; Aoki T; Morita M; Chishina H; Komeda Y; Yoshida A; Hayashi H; Nakagawa K; Kudo M
Hepatol Res; 2022 Sep; 52(9):754-761. PubMed ID: 35635496
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of occult hepatitis B in chronic hepatitis C patients treated with interferon-based antiviral therapy.
Bal T; Onlen Y
Arab J Gastroenterol; 2018 Mar; 19(1):33-36. PubMed ID: 29503077
[TBL] [Abstract][Full Text] [Related]
24. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
Chen FW; Coyle L; Jones BE; Pattullo V
Liver Int; 2013 Sep; 33(8):1203-10. PubMed ID: 23522150
[TBL] [Abstract][Full Text] [Related]
25. Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy.
Zhang X; Tian D; Chen Y; Chen C; He LN; Zhou Y; Li H; Lin Z; Chen T; Wang Y; Russo A; Nadal E; Passiglia F; Soo RA; Watanabe S; Moran T; Oh IJ; Fu S; Hong S; Zhang L
Transl Lung Cancer Res; 2021 Jul; 10(7):3191-3202. PubMed ID: 34430357
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection.
Megna M; Patruno C; Bongiorno MR; Gambardella A; Guarneri C; Romita P; Raimondo A; Loconsole F; Fabbrocini G
Clin Drug Investig; 2022 Jun; 42(6):525-531. PubMed ID: 35633470
[TBL] [Abstract][Full Text] [Related]
27. Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21.
Giordano C; Picardi M; Pugliese N; Vincenzi A; Abagnale DP; De Fazio L; Giannattasio ML; Fatigati C; Ciriello M; Salemme A; Muccioli Casadei G; Vigliar E; Mascolo M; Troncone G; Pane F
Front Oncol; 2023; 13():1130899. PubMed ID: 36890828
[TBL] [Abstract][Full Text] [Related]
28. Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper.
Sarmati L; Andreoni M; Antonelli G; Arcese W; Bruno R; Coppola N; Gaeta GB; Galli M; Girmenia C; Mikulska M; Pane F; Perno CF; Picardi M; Puoti M; Rambaldi A; Svicher V; Taliani G; Gentile G
Clin Microbiol Infect; 2017 Dec; 23(12):935-940. PubMed ID: 28668466
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.
Hwang JP; Feld JJ; Hammond SP; Wang SH; Alston-Johnson DE; Cryer DR; Hershman DL; Loehrer AP; Sabichi AL; Symington BE; Terrault N; Wong ML; Somerfield MR; Artz AS
J Clin Oncol; 2020 Nov; 38(31):3698-3715. PubMed ID: 32716741
[TBL] [Abstract][Full Text] [Related]
30. Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study.
Lasagna A; Albi G; Maserati R; Zuccarini A; Quaccini M; Baldanti F; Sacchi P; Bruno R; Pedrazzoli P
Front Oncol; 2023; 13():1044098. PubMed ID: 36761977
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B Reactivation in Liver Transplant Recipients With Hepatitis B Virus Core Antibody Positive Grafts: a Retrospective Study.
Khiangte B; Kothakota SR; Sasidharan M; Kareem H; Nair AK; Kumar VV; Kanala JR; Kumar PC
J Clin Exp Hepatol; 2020; 10(6):548-554. PubMed ID: 33311891
[TBL] [Abstract][Full Text] [Related]
32. Current Knowledge of Occult Hepatitis B Infection and Clinical Implications.
Yip TC; Wong GL
Semin Liver Dis; 2019 May; 39(2):249-260. PubMed ID: 30912100
[TBL] [Abstract][Full Text] [Related]
33. Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non-small-cell lung cancer patients.
Yao ZH; Liao WY; Ho CC; Chen KY; Shih JY; Chen JS; Lin ZZ; Lin CC; Yang JC; Yu CJ
Eur J Cancer; 2019 Aug; 117():107-115. PubMed ID: 31279301
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy.
Su YC; Lin PC; Yu HC; Wu CC
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):925-929. PubMed ID: 29621049
[TBL] [Abstract][Full Text] [Related]
35. Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists.
Pauly MP; Tucker LY; Szpakowski JL; Ready JB; Baer D; Hwang J; Lok AS
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1964-1973.e1. PubMed ID: 29702293
[TBL] [Abstract][Full Text] [Related]
36. Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B.
Lee HL; Jang JW; Han JW; Lee SW; Bae SH; Choi JY; Han NI; Yoon SK; Kim HJ; Lee S; Cho SG; Min CK; Kim DW; Lee JW
Dig Dis Sci; 2019 Oct; 64(10):2992-3000. PubMed ID: 30982209
[TBL] [Abstract][Full Text] [Related]
37. Screening for and management of hepatitis B virus reactivation in patients treated with anti-B-cell therapy.
Kusumoto S; Tobinai K
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):576-83. PubMed ID: 25696914
[TBL] [Abstract][Full Text] [Related]
38. Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment.
Lee PH; Huang YH; Hsu YW; Chen KC; Hsu KH; Lin H; Lee TY; Tseng JS; Chang GC; Yang TY
J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615034
[TBL] [Abstract][Full Text] [Related]
39. Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B.
Puri P
J Clin Exp Hepatol; 2013 Dec; 3(4):301-12. PubMed ID: 25755518
[TBL] [Abstract][Full Text] [Related]
40. A multicenter evaluation of hepatitis B reactivation with and without antiviral prophylaxis after kidney transplantation.
Shaikh SA; Kahn J; Aksentijevic A; Kawewat-Ho P; Bixby A; Rendulic T; Park JM
Transpl Infect Dis; 2022 Feb; 24(1):e13751. PubMed ID: 34725887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
